Press release

Press release – 11.04.2018

Theraclion accelerates its sales and clinical development in Asia

Theraclion sells first Echopulse system to Catalonia, Spain

Theraclion Accelerates its Growth in 2017

Theraclion nominates a new Non-Executive Director: Mr Renaud Saleur

Theraclion Reports First Presentation of Results for Breast Cancer Strategy

Theraclion presents its Echopulse at CES 2018

Theraclion significant achievement with its immunotherapy breast cancer strategy

First patient treatments by Theraclion’s Echopulse® in Poland

First 5 Theraclion Echopulse systems delivered to China

Reimbursement to 15 Million German